105 related articles for article (PubMed ID: 10816691)
1. The expression of alpha-MSH by melanocytes is reduced in vitiligo.
Graham A; Westerhof W; Thody AJ
Ann N Y Acad Sci; 1999 Oct; 885():470-3. PubMed ID: 10816691
[No Abstract] [Full Text] [Related]
2. MYG1, novel melanocyte related gene, has elevated expression in vitiligo.
Kingo K; Philips MA; Aunin E; Luuk H; Karelson M; Rätsep R; Silm H; Vasar E; Kõks S
J Dermatol Sci; 2006 Nov; 44(2):119-22. PubMed ID: 16996721
[No Abstract] [Full Text] [Related]
3. Immunohistochemical study of ACTH and alpha-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture.
Ichimiya M
J Dermatol; 1999 Aug; 26(8):502-6. PubMed ID: 10487004
[TBL] [Abstract][Full Text] [Related]
4. Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC.
Slominski A
Exp Dermatol; 1998 Aug; 7(4):213-6. PubMed ID: 9758420
[No Abstract] [Full Text] [Related]
5. Alpha-melanocyte-stimulating hormone in primary biliary cirrhosis.
Bergasa NV; Vergalla J; Turner ML; Loh PY; Jones EA
Ann N Y Acad Sci; 1993 May; 680():454-8. PubMed ID: 8390167
[No Abstract] [Full Text] [Related]
6. ACTH acts directly on melanocytes to stimulate melanogenesis--an in vitro study.
Iyengar B; Misra RS; Subalakshmi
Indian J Pathol Microbiol; 1995 Oct; 38(4):399-402. PubMed ID: 9726151
[TBL] [Abstract][Full Text] [Related]
7. Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.
Mosenson JA; Flood K; Klarquist J; Eby JM; Koshoffer A; Boissy RE; Overbeck A; Tung RC; Le Poole IC
Pigment Cell Melanoma Res; 2014 Mar; 27(2):209-20. PubMed ID: 24354861
[TBL] [Abstract][Full Text] [Related]
8. Silk Fibroin-Based Hydrogel Microneedles Deliver α-MSH to Promote Melanosome Delivery for Vitiligo Treatment.
Chong S; Wei C; Feng L; Guo R
ACS Biomater Sci Eng; 2023 Jun; 9(6):3368-3378. PubMed ID: 37115665
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo.
Spencer JD; Gibbons NC; Rokos H; Peters EM; Wood JM; Schallreuter KU
J Invest Dermatol; 2007 Feb; 127(2):411-20. PubMed ID: 16946714
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Notch signaling: a potential pathomechanism of vitiligo.
Diao JS; Zhang X; Xia WS; Zheng Y; Ren J; Wang YM; Gong Z; Xia W; Guo SZ
Med Hypotheses; 2009 Jul; 73(1):70-2. PubMed ID: 19269111
[TBL] [Abstract][Full Text] [Related]
11. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
12. Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Br J Dermatol; 1997 Aug; 137(2):171-8. PubMed ID: 9292062
[TBL] [Abstract][Full Text] [Related]
13. A fully functional proopiomelanocortin/melanocortin-1 receptor system regulates the differentiation of human scalp hair follicle melanocytes.
Kauser S; Thody AJ; Schallreuter KU; Gummer CL; Tobin DJ
Endocrinology; 2005 Feb; 146(2):532-43. PubMed ID: 15498881
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
Seleit I; Bakry OA; Abdou AG; Dawoud NM
Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
[TBL] [Abstract][Full Text] [Related]
15. Altered levels of LXR-α: crucial implications in the pathogenesis of vitiligo.
Kumar R; Parsad D; Kanwar AJ; Kaul D
Exp Dermatol; 2012 Nov; 21(11):853-8. PubMed ID: 23163651
[TBL] [Abstract][Full Text] [Related]
16. Uveal melanocytes do not respond to or express receptors for alpha-melanocyte-stimulating hormone.
Li L; Hu DN; Zhao H; McCormick SA; Nordlund JJ; Boissy RE
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4507-12. PubMed ID: 17003446
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic features in vitiligo.
Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
[TBL] [Abstract][Full Text] [Related]
18. [Alpha-melanocyte-stimulating hormone. Its current significance for dermatology].
Böhm M; Luger TA
Hautarzt; 2004 May; 55(5):436-45. PubMed ID: 15085280
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
20. [DNA synthesis in melanocytes during vitiligo].
Tschernosemski I; Petkov I; Durmischev A; Zlatkov NB
Dermatol Monatsschr; 1978 Mar; 164(3):180-5. PubMed ID: 658568
[No Abstract] [Full Text] [Related]
[Next] [New Search]
